O-(4-Hydroxy-3,5-diiodophenyl)-3-iodotyrosine(CAS: 5817-39-0)

O-(4-Hydroxy-3,5-diiodophenyl)-3-iodotyrosine (CAS: 5817-39-0) is regulated under various guidelines including the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) in the EU, and the Toxic Substances Control Act (TSCA) in the USA. Specific regulations may also include FDA and EPA requirements for safety handling and environmental protection.

Synthesis alternatives to O-(4-Hydroxy-3,5-diiodophenyl)-3-iodotyrosine (CAS: 5817-39-0) may include using related analogs or isomers such as O-(3,5-diiodophenyl)-3-iodotyrosine or other iodinated tyrosine derivatives. Common substituent reagents might include similar halogenated or iodinated compounds, but the choice depends on the specific application and desired properties.

The market for O-(4-Hydroxy-3,5-diiodophenyl)-3-iodotyrosine (CAS: 5817-39-0) is driven by its use in research for thyroid hormone modulation and as a potential drug candidate. Research trends include investigations into its biological activity and potential therapeutic applications, as well as efforts to develop more efficient synthesis methods and reduce costs.

Waste containing O-(4-Hydroxy-3,5-diiodophenyl)-3-iodotyrosine (CAS: 5817-39-0) should be collected and disposed of according to regulatory guidelines. Incineration or professional waste disposal services are recommended to ensure environmental protection. Proper precautions should be taken to prevent contamination and ensure safe handling during waste collection and disposal processes.